Schedule 13D ownership disclosure

Checkmate Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 162818108

Event date: 2020-08-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,606,707
Percent of class
16.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-096782
Form type
SC 13D
Filer
Checkmate Pharmaceuticals, Inc.
CIK
CIK 1651431
Filed
Aug 19, 2020
Reporting period
Aug 11, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub